The HARMONY Big Data Platform offers a wide range of anynomized data such as:
Safe and secure data
The HARMONY Big Data Platform has identified clinical data from over 70,000 European patients. This will enable HARMONY Research Project Teams to characterize the molecular landscape of the key blood cancers, understand their pathophysiology, and identify novel drug targets. In addition, it will allow to reliably predict disease course and drug response for subgroups of patients. Ultimately, this should result in tools to rapidly select the most promising treatment strategy for a particular patient. In parallel, we are developing core outcome sets for blood cancers and organizing multi-stakeholder activities.
Receive the latest news. Click here to subscribe!